The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Michael Rosen named chief communications officer at Pancreatic Cancer Action Network

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

Michael Rosen was named chief communications officer at the Pancreatic Cancer Action Network.

One of Rosen’s key roles will be increasing awareness about the organization’s ground breaking research and clinical initiatives like Precision Promise, a revolutionary clinical trial that will dramatically accelerate progress and bring promising therapies to patients faster.

Most recently, Rosen served as executive vice president of marketing and communications for the Mental Health Association of New York City, where he managed all marketing, communications strategies and development.

Between 2013 and 2016, Rosen led strategic communications for Autism Speaks, the world’s largest autism advocacy organization.

Prior to entering the nonprofit sector, Rosen was the executive producer first of The Saturday Early Show and then CBS This Morning Saturday. At ABC News, Rosen was second in charge for the network’s Peabody Award-winning coverage of 9/11, and covered the war in Kosovo on location. Rosen has won three Emmy Awards, two Peabody Awards and four DuPont Awards.

Table of Contents

YOU MAY BE INTERESTED IN

ClinicalTrials & Tribulations

The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
By W. Kimryn Rathmell

At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer

If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
By Sara Willa Ernst, Claire Marie Porter and Paul Goldberg

Eric Small, ASCO’s immediate past president, speaks on the toll of toxicity—financial, emotional, physical—in cancer
“Discovery alone is not enough. It’s about what becomes of what we discover. It’s about translation.”

In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 
By Claire Marie Porter
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account